Second-trimester double or triple screening for Down syndrome: A comparison of Chinese and Caucasian populations

International Journal of Gynecology and Obstetrics

Volumn 94, Issue 1, 2006, Pages 67-72

  Wang, Yuan Yuan ^a,b   Luo, Jun ^c   Zhu, Ming Wei ^d   Liu, Lan Nv ^e   Ma, Xu ^a,b  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c China Welfare Institute   (China)

^d FUDAN UNIVERSITY   (China)

^e Maternal and Fetal Health Hospital   (China)

Author keywords

Alpha fetoprotein; Down syndrome; Human chorionic gonadotrophin; Prenatal screening; Unconjugated estriol

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL;

ADULT; ARTICLE; CALCULATION; CAUCASIAN; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN SYNDROME; ETHNOLOGY; FALSE POSITIVE RESULT; FEMALE; FETUS; GESTATION PERIOD; HUMAN; MATERNAL AGE; PERFORMANCE; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

EID: 33745518440     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.04.030     Document Type: Article

References (20)

1. Hershey D.W., Crandall B.F., and Perdue S. Combining maternal age and serum alpha-fetoprotein to predict the risk of Down syndrome. Obstet Gynecol 68 2 (1986) 177-180
2. Phillips O.P., Elias S., Shulman L.P., Andersen R.N., Morgan C.D., and Simpson J.L. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Obstet Gynecol 80 3 Pt 1 (1992) 353-358
3. Thornton J.G., Cartmill R.S., Williams J., Holding S., and Lilford R.J. Clinical experience with the triple test for Down's syndrome screening. J Perinat Med 19 3 (1991) 151-154
4. Nicolaides K.H., Heath V., and Cicero S. Increased fetal nuchal translucency at 11-14 weeks. Prenat Diagn 22 4 (2002) 308-315
5. Wald N.J., Rodeck C., Hackshaw A.K., Walters J., Chitty L., and Mackinson A.M. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 7 11 (2003) 1-77
6. Snijders R.J., Noble P., Sebire N., Souka A., and Nicolaides K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10 214 weeks of gestation. Lancet 352 (1998) 343-346
7. Thilaganathan B., Sairam S., Michailidis G., and Wathen N.C. First trimester nuchal translucency: effective routine screening for Down's syndrome. Br J Radiol 72 (1999) 946-948
8. Spencer K., Heath V., El-Sheikhah A., Ong C.Y., and Nicolaides K.H. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 25 5 (2005) 365-369
9. O'Brien J.E., Dvorin E., Drugan A., Johnson M.P., Yaron Y., and Evans M.I. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstet Gynecol Mar 89 3 (1997) 355-358
10. Heyl P.S., Miller W., and Canick J.A. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 76 6 (1990) 1025-1031
11. Cuckle H.S., Wald N.J., and Thompson S.G. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94 5 (1987) 387-402
12. MacRae A.R., Gardner H.A., Allen L.C., Tokmakejian S., and Lepage N. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application. Clin Chem 49 1 (2003) 69-76
13. Lau T.K., Fung H.Y., Rogers M.S., and Cheung K.L. Racial variation in incidence of trisomy 21: survey of 57,742 Chinese deliveries. Am J Med Genet 75 4 (1998) 386-388
14. Cuckle H.S., Wald N.J., and Lindenbaum R.H. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1 8383 (1984) 926-929
15. Wald NJ, Kennard A, Hackshaw A, Mc Guire. A. screening of down's syndrome. Health Technol Assessment 1998; 2 (1): i-iv, 1-112.
16. Benn P.A., Clive J.M., and Collins R. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: differences between races or ethnic groups. Clin Chem 43 2 (1997) 333-337
17. O'Brien J.E., Dvorin E., Drugan A., Johnson M.P., Yaron Y., and Evans M.I. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstet Gynecol 89 3 (1997) 355-358
18. Hsu J.J., Hsieh T.T., Hung T.H., and Chiang C.H. Midtrimester maternal serum free beta-human chorionic gonadotropin levels: normal reference values for Taiwanese women. Changgeng Yi Xue Za Zhi 21 3 (1998) 277-282
19. Law L., Lau T., Fung T., Rogers M.S., and Hjelm M. Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong. Chin Med J (Eng) 112 8 (1999) 754-757
20. Wenstrom K.D., Owen J., Boots L., and Ethier M. The influence of maternal weight on human chorionic gonadotropin in the multiple-marker screening test for fetal Down syndrome. Prenat Diagn 14 7 (1994) 633-636